Bariatric surgery versus intensive medical therapy in obese patients with diabetes

New England Journal of Medicine

Volumn 366, Issue 17, 2012, Pages 1567-1576

  Schauer, Philip R ^a   Kashyap, Sangeeta R ^a   Wolski, Kathy ^a   Brethauer, Stacy A ^a   Kirwan, John P ^a   Pothier, Claire E ^a   Thomas, Susan ^a   Abood, Beth ^a   Nissen, Steven E ^a   Bhatt, Deepak L ^b,c,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; GROWTH HORMONE SECRETAGOGUE; HEMOGLOBIN; INCRETIN; INSULIN;

ADULT; ADVERSE OUTCOME; ANEMIA; ARTICLE; BARIATRIC SURGERY; BLOOD CLOTTING; BLOOD PRESSURE MEASUREMENT; CELLULITIS; CHOLECYSTECTOMY; CHOLELITHIASIS; CLINICAL EVALUATION; CONTROLLED STUDY; DEHYDRATION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HERNIA; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; INTENSIVE CARE; INTERMETHOD COMPARISON; INTRAVENOUS ADMINISTRATION; JEJUNOSTOMY; JEJUNUM ULCER; KETOACIDOSIS; KIDNEY FAILURE; LAPAROSCOPY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MONOTHERAPY; NAUSEA; NEPHROLITHIASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; THERAPY EFFECT; TREATMENT OUTCOME; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; WOUND INFECTION;

EID: 84860136615     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1200225     Document Type: Article

References (22)

1. Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378:31-40.
2. Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203.
3. The Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 2007; 30:1374-83.
4. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-42. (Pubitemid 38101606)
5. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122(3):248.e5-256.e5.
6. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-84.
7. Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 2005;28:2406-11. (Pubitemid 41384285)
8. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-93. (Pubitemid 39665322)
9. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-50.
10. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008;299: 316-23. (Pubitemid 351159368)
11. Kashyap SR, Bhatt DL, Schauer PR. Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE). Diabetes Obes Metab 2010;12:452-4. [Erratum, Diabetes Obes Metab 2010;12:833.]
12. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care 2011;34:Suppl 1:S11-S61.
13. Schauer PR, Ikramuddin S, Hamad G, et al. Laparoscopic gastric bypass surgery: current technique. J Laparoendosc Adv Surg Tech A 2003;13:229-39. (Pubitemid 37082439)
14. Eldar S, Heneghan HM, Brethauer S, Schauer PR. A focus on surgical preoperative evaluation of the bariatric patient -the Cleveland Clinic protocol and review of the literature. Surgeon 2011;9:273-7.
15. Gill RS, Birch DW, Shi X, Sharma AM, Karmali S. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis 2010;6:707-13.
16. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs. sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg 2011;146:143-8.
17. Cummings DE, Overduin J, Shannon MH, Foster-Schubert KE. Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery. Surg Obes Relat Dis 2005;1:358-68.
18. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010;34:462-71.
19. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 2007;3:597-601. (Pubitemid 350091417)
20. Laferrère B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 2007;30:1709-16. (Pubitemid 47036341)
21. The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the Longitudinal Assessment of Bariatric Surgery. N Engl J Med 2009;361:445-54.
22. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007;357:753-61. (Pubitemid 47295642)